Home › Funds › ROCKLAND TRUST CO › ELV

ROCKLAND TRUST CO position in ELV

ELEVANCE HEALTH INC FORMERLY · Health Care

ROCKLAND TRUST CO reported holding 69,130 shares of ELV (ELEVANCE HEALTH INC FORMERLY) in its Q3 2026 13F filing — a position valued at US$26.9M, representing 1.03% of its reported portfolio and ranking #26 among its reported holdings. ROCKLAND TRUST CO has disclosed ELV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)69.13K sh
Reported value held$26.88M
Portfolio Weight1.03%
First reportedQ3 2023
Last changeAdd
Updated2026-10-09

Last updated: 2026-10-09 · Source: SEC EDGAR Form 13F-HR

How ROCKLAND TRUST CO's ELV position evolved

ROCKLAND TRUST CO first disclosed a stake in ELV in Q3 2023 at 485 shares (US$211K). The position peaked in Q3 2026 at 69,130 shares, worth US$26.9M. Across 13 filings, ROCKLAND TRUST CO increased the stake 8 time(s), trimmed it 3 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 69,130 shares valued at US$26.9M — an increase of 663 shares quarter over quarter.. Notable position changes include a 47% increase in Q1 2025 (shares fell 10% over the following quarter), a 8252% increase in Q4 2025 (shares fell 16% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 485 $211.18K New
Q4 2023 501 $236.25K Add
Q1 2024 455 $235.94K Reduce
Q2 2024 507 $274.72K Add
Q3 2024 602 $313.04K Add
Q4 2024 595 $219.50K Reduce
Q1 2025 873 $379.72K Add
Q2 2025 767 $298.33K Reduce
Q3 2025 770 $248.80K Hold
Q4 2025 64.31K $22.54M Add
Q1 2026 67.16K $19.66M Add
Q2 2026 68.47K $26.48M Add
Q3 2026 69.13K $26.88M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ELV and 13F data

ELV (ELEVANCE HEALTH INC FORMERLY) is a Health Care company. 23 other funds we track also report a position in ELV — the largest reported positions include Wellington Management Group (US$3.56B), WELLINGTON MANAGEMENT GROUP LLP (US$3.56B), Sanders Capital, LLC (US$2.25B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ELV

All ELV fund holders →

FAQ

How long has ROCKLAND TRUST CO held ELV?

ROCKLAND TRUST CO has disclosed ELV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is ROCKLAND TRUST CO's current position in ELV?

As of Q3 2026, ROCKLAND TRUST CO holds 69.13K shares of ELV (ELEVANCE HEALTH INC FORMERLY), valued at $26.88M, representing 1.03% of its reported portfolio and ranking #26.

Has ROCKLAND TRUST CO been buying or selling ELV?

In the latest 13F filing (Q3 2026), ROCKLAND TRUST CO increased its position in ELV. The position peaked in Q3 2026 at 69.13K shares.

Which other funds hold ELV?

Other major institutional holders of ELV include Wellington Management Group, WELLINGTON MANAGEMENT GROUP LLP, Sanders Capital, LLC, among 23 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.